Bexxar (Tositumomab) Protocol CP98-020: Results with I-131 Labeled Antibody in Patients with Follicular Non-Hodgkin's Lymphoma Refractory to Chemotherapy and Rituxan (Rituximab): 5 Year Follow-up in 60 Cases

Subjects

Subjects :

Oncology
Cancer Research
Chemotherapy
medicine.medical_specialty
Radiation
5 year follow up
biology
business.industry
medicine.medical_treatment
Tositumomab
Follicular Non-Hodgkin's Lymphoma
Refractory
Internal medicine
biology.protein
Medicine
Radiology, Nuclear Medicine and imaging
Rituximab
In patient
Antibody
business
medicine.drug

Details

ISSN :

03603016

Volume :

75

Database :

OpenAIRE

Journal :

International Journal of Radiation Oncology*Biology*Physics

Accession number :

edsair.doi...........929f2af7d9f69144d85a08997f63a2a1

Full Text :

https://doi.org/10.1016/j.ijrobp.2009.07.1093